Results 191 to 200 of about 229,211 (212)
A multifunctional nanoagonist (cDZ@IP) enables nano‐metabolite–driven multimodal activation of the STING pathway and enhanced immune recognition, achieving potent antitumor immunity and suppressing tumor growth and metastasis. This strategy highlights the rational design of therapeutic metabolites and establishes a new paradigm bridging nanomedicine ...
Kepeng Hu +17 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
FDG PET Metabolic Tumor Volume Segmentation and Pathologic Volume of Primary Human Solid Tumors
American Journal of Roentgenology, 2014Praveen Sridhar +2 more
exaly
Postradiation Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer
International Journal of Radiation Oncology Biology Physics, 2011James D Murphy, Karen Chu, Andrew Quon
exaly
Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck Cancer
International Journal of Radiation Oncology Biology Physics, 2009Edward E Graves
exaly
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer
Gynecologic Oncology, 2011Hyun Hoon Chung +2 more
exaly

